Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

129 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ASSERT-III study aims to determine the incidence of sub-clinical (silent) atrial fibrillation (AF) among elderly patients with hypertension and at least one other risk factor for AF. This will be accomplished by monitoring with a wireless external loop monitor for 30 to 60 days.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor

NCT01694394

Atrial Fibrillation

COMPLETED

Reversal of Atrial Substrate to Prevent Atrial

NCT03682991

Atrial Fibrillation

RECRUITING NA

Program for the Identification of "Actionable" Atrial Fibrillation in the Family Practice Setting

NCT02262351

Atrial Fibrillation

COMPLETED NA

Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients

NCT04818645

Atrial Fibrillation Heart Failure

RECRUITING NA

A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With Hypertension

NCT02585076

Hypertension Atrial Fibrillation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elderly Hypertension Risk Factors for Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients will be eligible for inclusion if they meet all of the following:

1. Age ≥ 80 years
2. History of hypertension OR a blood pressure of ≥ 140/90 mmHg
3. Attending a primary care clinic, OR ambulatory resident of a chronic care facility
4. At least one of the following additional risk factors for developing AF:

1. Diabetes
2. Body mass index ≥ 30
3. History of smoking
4. Documented Obstructive sleep apnea
5. Cardiovascular disease
6. Heart Failure
7. Left ventricular hypertrophy (on ECG or echocardiography)
5. Provide written informed consent

Exclusion Criteria

1. ECG documented history of AF or atrial flutter, with an episode duration ≥ 6 minutes
2. Existing implanted pacemaker or defibrillator
3. Patients considered by the investigator to be unsuitable for study follow-up because the patient:

1. is unreliable concerning the requirements for follow-up during the study and/or compliance with the use of the external loop recorder
2. has a life expectancy less that the expected study duration due to concomitant disease
3. has a condition which in the opinion of the investigator, would not allow current chronic treatment with anticoagultion -

Minimum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No